Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
British Journal of Cancer|November 1, 1994
Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumoursA Gerl, C Clemm, N Schmeller, et al.British Journal of Cancer|December 17, 2003
Subjective quality of life and sexual functioning after germ-cell tumour therapyM J Fegg, A Gerl, T C Vollmer, et al.Gut|July 1, 1992
Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoidA Gerl, M Storck, A Schalhorn, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patientsR D Issels, J Mittermüller, A Gerl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, A Gerl, P Schöffski, et al.The Journal of Urology|August 1, 1997
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study GroupE W Steyerberg, J P Donohue, A Gerl, et al.International Journal of Cancer|December 22, 1999
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG)C Bokemeyer, C Kollmannsberger, A Harstrick, et al.Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.Cancer|June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumorsJ T Hartmann, C R Nichols, J-P Droz, et al.Pageof 6